BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2958609)

  • 1. Tissue renin-angiotensin systems: focus on the heart.
    Lindpaintner K; Wilhelm MJ; Jin M; Unger T; Lang RE; Schoelkens BA; Ganten D
    J Hypertens Suppl; 1987 Jul; 5(2):S33-8. PubMed ID: 2958609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
    Clauser E
    Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
    Lindpaintner K; Ganten D
    Cardiology; 1991; 79 Suppl 1():32-44. PubMed ID: 1655263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.
    Lindpaintner K; Jin MW; Niedermaier N; Wilhelm MJ; Ganten D
    Circ Res; 1990 Sep; 67(3):564-73. PubMed ID: 2204498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1993 Oct; 22(4):513-22. PubMed ID: 8406656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
    Unger T; Ganten D; Lang RE
    Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local angiotensin II generation in the rat heart: role of renin uptake.
    Müller DN; Fischli W; Clozel JP; Hilgers KF; Bohlender J; Ménard J; Busjahn A; Ganten D; Luft FC
    Circ Res; 1998 Jan 9-23; 82(1):13-20. PubMed ID: 9440700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac renin-angiotensin system. Molecular and functional aspects.
    Dzau VJ
    Am J Med; 1988 Mar; 84(3A):22-7. PubMed ID: 3218653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramipril: review of pharmacology.
    Becker RA; Schölkens B
    Am J Cardiol; 1987 Apr; 59(10):3D-11D. PubMed ID: 3034030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracardiac generation of angiotensin and its physiologic role.
    Lindpaintner K; Jin M; Wilhelm MJ; Suzuki F; Linz W; Schoelkens BA; Ganten D
    Circulation; 1988 Jun; 77(6 Pt 2):I18-23. PubMed ID: 3286043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an internal cardiac renin-angiotensin system?
    Danser AH; Schalekamp MA
    Heart; 1996 Nov; 76(3 Suppl 3):28-32. PubMed ID: 8983664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interference with the cardiac renin-angiotensin system.
    Becker RH; Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S10-5. PubMed ID: 2483422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiac renin-angiotensin system: a synopsis of current experimental and clinical data.
    Lindpaintner K; Ganten D
    Acta Cardiol; 1991; 46(3):385-97. PubMed ID: 1927165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
    Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T
    Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.
    Grimm D; Elsner D; Schunkert H; Pfeifer M; Griese D; Bruckschlegel G; Muders F; Riegger GA; Kromer EP
    Cardiovasc Res; 1998 Jan; 37(1):91-100. PubMed ID: 9539862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.